Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis (Q34027590)

30 July 2017

1 reference

title

Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis (English)

1 reference

30 July 2017

H L Bonkovsky

1

1 reference

PubMed ID

10980924

30 July 2017

J V Obando

series ordinal

2

1 reference

30 July 2017

1 February 1999

1 reference

Current gastroenterology reports

30 July 2017

1 reference

30 July 2017

1

1 reference

30 July 2017

1

1 reference

30 July 2017

30-37

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-999-0084-5

30 July 2017

0 references

cites work

Experimental liver cirrhosis induced by alcohol and iron

1 reference

12 December 2020

Enhanced phenotypic expression of alpha-1-antitrypsin deficiency in an MZ heterozygote with chronic hepatitis C.

1 reference

12 December 2020

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

12 December 2020

Response to interferon alpha therapy is influenced by the iron content of the liver

1 reference

12 December 2020

Iron in liver diseases other than hemochromatosis

1 reference

12 December 2020

Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.

1 reference

12 December 2020

Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis

1 reference

12 December 2020

Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection

1 reference

12 December 2020

Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation.

1 reference

12 December 2020

Postshunt hemochromatosis with cardiomyopathy

1 reference

12 December 2020

Iron metabolism in patients with porta-caval shunts

1 reference

12 December 2020

Measurements of iron status in patients with chronic hepatitis

1 reference

12 December 2020

Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America

1 reference

12 December 2020

Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload

1 reference

12 December 2020

Mechanism of iron potentiation of hepatic uroporphyria: studies in cultured chick embryo liver cells

1 reference

12 December 2020

A detailed analysis of the Knodell score and other histologic parameters as predictors of response to interferon therapy in chronic hepatitis C

1 reference

12 December 2020

Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C.

1 reference

12 December 2020

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

1 reference

12 December 2020

Iron and chronic viral hepatitis

1 reference

12 December 2020

1 reference

12 December 2020

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

1 reference

12 December 2020

Iron overload in Africa. Interaction between a gene and dietary iron content

1 reference

12 December 2020

Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis

1 reference

12 December 2020

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

12 December 2020

Gastrojejunostomy inhibits postshunt siderosis

1 reference

12 December 2020

Development of hemosiderosis after side-to-side portacaval shunting

1 reference

12 December 2020

End-stage liver disease without hemochromatosis associated with elevated hepatic iron index

1 reference

12 December 2020

Hemosiderosis in cirrhosis: a study of 447 native livers

1 reference

12 December 2020

Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma

1 reference

12 December 2020

Iron, oxidative stress and liver fibrogenesis

1 reference

12 December 2020

No association between genetic hemochromatosis and alpha1-antitrypsin deficiency

1 reference

12 December 2020

Metal-induced hepatotoxicity

1 reference

12 December 2020

Relationships among serum iron status markers, chemical and histochemical liver iron content in 117 patients with alcoholic and non-alcoholic hepatic disease

1 reference

12 December 2020

Increased serum iron and iron saturation without liver iron accumulation distinguish chronic hepatitis C from other chronic liver diseases

1 reference

12 December 2020

Review: nonalcoholic steatohepatitis

1 reference

12 December 2020

Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis.

1 reference

12 December 2020

Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases

1 reference

12 December 2020

Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda

1 reference

12 December 2020

The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients

1 reference

12 December 2020

Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda

1 reference

12 December 2020

High prevalence of the His63Asp HFE mutation in italian patients with porphyria cutanea tarda

1 reference

12 December 2020

A 49-year-old man with alpha 1-antitrypsin deficiency and abnormal iron study results

1 reference

12 December 2020

Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C

1 reference

12 December 2020

10.1007/S11894-999-0084-5

Identifiers

DOI

1 reference

PubMed ID

10980924

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

10980924